Cencora, Inc. $COR Stake Trimmed by Vista Investment Partners LLC

Vista Investment Partners LLC lowered its stake in shares of Cencora, Inc. (NYSE:COR) by 96.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 686 shares of the company’s stock after selling 18,868 shares during the period. Vista Investment Partners LLC’s holdings in Cencora were worth $206,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of COR. Burr Financial Services LLC raised its stake in Cencora by 30.4% in the 3rd quarter. Burr Financial Services LLC now owns 1,714 shares of the company’s stock valued at $515,000 after acquiring an additional 400 shares during the period. Vann Equity Management LLC boosted its position in Cencora by 210.5% during the third quarter. Vann Equity Management LLC now owns 2,301 shares of the company’s stock worth $691,000 after purchasing an additional 1,560 shares during the period. Martin Capital Partners LLC increased its stake in shares of Cencora by 9.7% in the third quarter. Martin Capital Partners LLC now owns 3,187 shares of the company’s stock worth $957,000 after purchasing an additional 282 shares in the last quarter. Venture Visionary Partners LLC increased its stake in shares of Cencora by 86.1% in the third quarter. Venture Visionary Partners LLC now owns 3,119 shares of the company’s stock worth $936,000 after purchasing an additional 1,443 shares in the last quarter. Finally, Elevation Wealth Partners LLC raised its position in shares of Cencora by 942.3% in the third quarter. Elevation Wealth Partners LLC now owns 1,011 shares of the company’s stock valued at $304,000 after purchasing an additional 914 shares during the period. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Insider Buying and Selling

In other Cencora news, EVP Elizabeth Campbell sold 11,300 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $324.12, for a total value of $3,662,556.00. Following the completion of the transaction, the executive vice president owned 19,455 shares of the company’s stock, valued at $6,305,754.60. The trade was a 36.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.38% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of analysts recently commented on COR shares. Morgan Stanley upped their price target on shares of Cencora from $342.00 to $346.00 and gave the company an “overweight” rating in a research note on Friday, August 7th. Royal Bank Of Canada restated a “sector perform” rating and set a $330.00 target price on shares of Cencora in a research report on Tuesday, September 8th. Wells Fargo & Company lifted their price target on Cencora from $331.00 to $395.00 and gave the company an “overweight” rating in a research report on Tuesday, August 11th. Weiss Ratings upgraded Cencora from a “buy (b-)” rating to a “buy (b)” rating in a research note on Tuesday. Finally, Leerink Partners increased their price objective on Cencora from $380.00 to $388.00 and gave the stock an “outperform” rating in a report on Wednesday. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $372.07.

Cencora Price Performance

NYSE:COR traded up $3.22 during trading hours on Thursday, hitting $320.47. 294,091 shares of the company’s stock traded hands, compared to its average volume of 1,479,906. Cencora, Inc. has a 52 week low of $244.82 and a 52 week high of $377.54. The business’s fifty day simple moving average is $318.08 and its two-hundred day simple moving average is $302.75. The company has a quick ratio of 0.58, a current ratio of 0.93 and a debt-to-equity ratio of 3.53. The firm has a market cap of $61.16 billion, a P/E ratio of 23.81, a P/E/G ratio of 1.62 and a beta of 0.58.

Cencora (NYSE:COR) last announced its earnings results on Wednesday, August 5th. The company reported $4.48 earnings per share for the quarter, topping analysts’ consensus estimates of $4.35 by $0.13. The business had revenue of $84.75 billion for the quarter, compared to analyst estimates of $84.31 billion. Cencora had a return on equity of 125.45% and a net margin of 0.79%.The company’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the prior year, the company earned $4.00 EPS. On average, research analysts anticipate that Cencora, Inc. will post 17.87 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, August 31st. Shareholders of record on Friday, August 14th were paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend was Friday, August 14th. Cencora’s payout ratio is currently 17.83%.

About Cencora

Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical solutions company that sources, distributes and supports the delivery of medicines and healthcare products. The company serves pharmaceutical manufacturers, healthcare providers, pharmacies and animal-health customers through its supply-chain and commercialization services.

Its activities include pharmaceutical and specialty-product distribution, manufacturer services, specialty logistics, clinical-trial support, patient-support programs and other services designed to help bring medicines to market and improve access to treatment.